Uncategorised - European Medical Journal

Bimekizumab▼in hidradenitis suppurativa (HS)

Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and deep…

30 Jan 2026

Putting the Pieces Together: A Patient-Centred Approach to Bronchiectasis Diagnosis

Putting the Pieces Together: A Patient-Centred Approach to Bronchiectasis Diagnosis…

Recent Developments in NMIBC Research

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these cases…

Pharma factory surrounded by wind farms and solar panels

Pharma's annual climate report: ambition to execution

As pharma raced to meet climate targets in 2024-2025, it’s proving that scaling medicines doesn’t have to hurt the planet.

Gut Microbiome Predicts Response to Diabetes Drugs

Importantly, baseline gut microbiome profiles predicted changes in glycohaemoglobin among users of both therapies.

Adult with bronchial asthma using a nebulizer during a telemedicine video visit on a laptop at home

Telemedicine in Bronchial Asthma Improves Control and Quality of Life

Telemedicine in bronchial asthma improved asthma control, especially using telemonitoring, education, or combined support programs.

Hospital popping out of smart phone

TrumpRx: Guidance on DTC sales issued to industry

The Office of Inspector General’s bulletin provides a framework for pharma companies selling prescription drugs direct-to-consumers (DTC).

More Time Outdoors Linked to Higher Testosterone Levels in Men

Spending more time outdoors was linked to higher testosterone levels and lower odds of low testosterone in adult men, independent of lifestyle and metabolic factors.

AI Predicts Antidepressant Treatment Response with 97% Accuracy

Patients who responded to treatment showed increased Beta2 power, enhanced high-frequency functional connectivity, and dominant engagement of frontal brain networks.

Gut microbiota dysbiosis in the colon linked to colorectal cancer risk and screening biomarkers

Can Gut Microbiota Improve Colorectal Screening?

Gut microbiota dysbiosis may shape colorectal cancer risk, with microbial signatures emerging as non-invasive screening biomarkers.